MRD-Positive AML Patients Should Not Proceed Directly to Transplant Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(8):36, April 20, 2021. Favorites PDF Get Content & Permissions Free
More Strategies Needed to Eradicate Minimal Residual Disease in AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(8):34, April 20, 2021. Favorites PDF Get Content & Permissions Free
Deep Learning & Imaging Flow Cytometry for ALL Monitoring Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(7):1,14,17, April 5, 2021. Favorites PDF Get Content & Permissions Free
Reproducing Acute Lymphoblastic Leukemia Surface & Genetic Markers in Cells Holt, Chuck Holt, Chuck Less Oncology Times. 43(5):1,12, March 5, 2021. Favorites PDF Get Content & Permissions Free
New Maintenance Treatment for Acute Myeloid Leukemia Prolongs Lives Less Oncology Times. 43(4):26, February 20, 2021. Favorites PDF Get Content & Permissions Free
Scientists Create On-Off Switches to Control CAR T-Cell Activity Less Oncology Times. 43(4):1,12, February 20, 2021. Favorites PDF Get Content & Permissions Free
Novel Combination Therapy May Help Overcome mTOR Drug Resistance in AML Less Oncology Times. 43(2):24, January 20, 2021. Favorites PDF Get Content & Permissions Free
Decitabine/Cedazuridine (Inqovi®) Lovell, Alexandra Lovell, Alexandra Less Oncology Times. 43(2):15, January 20, 2021. Favorites PDF Get Content & Permissions Free
Venetoclax Combination Improves Outcomes for Patients With Mutated AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(2):1,12, January 20, 2021. Favorites PDF Get Content & Permissions Free
Precision Medicine Advances Positive Outcomes in AML Byrd, John C. Byrd, John C. Less Oncology Times. 43(2):1,11, January 20, 2021. Favorites PDF Get Content & Permissions Free
Chemotherapy Plus Blinatumomab Improves Survival for B-Cell ALL Patients Less Oncology Times. 43(1):1,6, January 5, 2021. Favorites PDF Get Content & Permissions Free
Young Survivors of Acute Myeloid Leukemia Have Long-Term Complications Less Oncology Times. 42(24):83-84, December 20, 2020. Favorites PDF Get Content & Permissions Free
Advances in Pediatric Acute Lymphoblastic Leukemia Treatment Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 42(24):6-7, December 20, 2020. Favorites PDF Get Content & Permissions Free Take the CME Test
Reducing GVHD While Retaining Anti-Cancer Effects Less Oncology Times. 42(23):29, December 5, 2020. Favorites PDF Get Content & Permissions Free
Findings Show Superior Patient Outcomes in Beat AML Clinical Trial Less Oncology Times. 42(23):1,16, December 5, 2020. Favorites PDF Get Content & Permissions Free
What Clinicians Treating MDS Patients Must Understand About the TP53 Gene Conick, Hal Conick, Hal Less Oncology Times. 42(21):1,10, November 5, 2020. Favorites PDF Get Content & Permissions Free
Azacitidine Tablets (Onureg®) Shultes, Kendall C. Shultes, Kendall C. Less Oncology Times. 42(20):11,35, October 20, 2020. Favorites PDF Get Content & Permissions Free
A Promising Way to Stop Leukemia Relapse Found in New Research Less Oncology Times. 42(19):1,14, October 5, 2020. Favorites PDF Get Content & Permissions Free
A New Standard of Care for Acute Myeloid Leukemia Holt, Chuck Holt, Chuck Less Oncology Times. 42(19):1,6,14, October 5, 2020. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... The Long-Term Benefits of Risk-Stratified Therapy for Childhood ALL: With Stephanie Dixon, MD, of St. Jude Children's Research Hospital DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 42(18):50, September 20, 2020. Favorites PDF Get Content & Permissions Free
New Clinical Practice Guidelines on AML in Older Adults Less Oncology Times. 42(17):1,14, September 5, 2020. Favorites PDF Get Content & Permissions Free
Dual Inhibitor May Be Safer for Chronic Lymphocytic Leukemia Patients Less Oncology Times. 42(15):30, August 5, 2020. Favorites PDF Get Content & Permissions Free
Pathogens Suppress Immune Response With Molecule Less Oncology Times. 42(15):1,29, August 5, 2020. Favorites PDF Get Content & Permissions Free
Long-Term Results Support Efficacy of Ublituximab + Ibrutinib in High-Risk CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(14):36, July 20, 2020. Favorites PDF Get Content & Permissions Free
Long-Term Results Support Efficacy of Ublituximab + Ibrutinib in High-Risk CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(14):36, July 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Medicine Treatments for Children With Leukemia Less Oncology Times. 42(14):1,9, July 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Medicine Treatments for Children With Leukemia Less Oncology Times. 42(14):1,9, July 20, 2020. Favorites PDF Get Content & Permissions Free
Initial Findings Show Promise of Triplet Therapy in CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(13):35, July 5, 2020. Favorites PDF Get Content & Permissions Free
Initial Findings Show Promise of Triplet Therapy in CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(13):35, July 5, 2020. Favorites PDF Get Content & Permissions Free
Bispecific CD19/CD22 CAR T Cells Show Promise in R/R ALL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(11):1,11, June 5, 2020. Favorites PDF Get Content & Permissions Free
Repurposing Classic Chemotherapy Drug to Overcome Therapy Resistance Less Oncology Times. 42(10):1,15, May 20, 2020. Favorites PDF Get Content & Permissions Free
Advances in Dendritic Cell-Based Therapies for Hematologic Malignancies Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 42(8):1,20-21, April 20, 2020. Favorites PDF Get Content & Permissions Free
Cells Leading to Relapse in Acute Lymphoblastic Leukemia Less Oncology Times. 42(6):1,11, March 20, 2020. Favorites PDF Get Content & Permissions Free
CD19 CAR NK-Cell Therapy in Leukemia & Lymphoma Less Oncology Times. 42(5):35, March 5, 2020. Favorites PDF Get Content & Permissions Free
Ibrutinib Plus Venetoclax Shows Promise as First-Line Treatment for CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(3):36, February 5, 2020. Favorites PDF Get Content & Permissions Free
Disparities in Kidney Function Should Not Exclude Minorities From AML Studies Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(3):35, February 5, 2020. Favorites PDF Get Content & Permissions Free
Pediatric AML Management After Chemo: Outpatient vs. Inpatient Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(3):34,36, February 5, 2020. Favorites PDF Get Content & Permissions Free
Ibrutinib & Venetoclax as First-Line CLL/SLL Treatment Holt, Chuck Holt, Chuck Less Oncology Times. 42(3):33, February 5, 2020. Favorites PDF Get Content & Permissions Free
A Possible Vaccine for Acute Myeloid Leukemia? Less Oncology Times. 42(3):1,13, February 5, 2020. Favorites PDF Get Content & Permissions Free
Artificial Intelligence Tracks Down Acute Myeloid Leukemia Less Oncology Times. 42(2):33, January 20, 2020. Favorites PDF Get Content & Permissions Free
Acute Leukemia Patients May Have Increased Risk for Heart Failure Less Oncology Times. 42(2):1,15, January 20, 2020. Favorites PDF Get Content & Permissions Free
Putting the Brakes on Dismal Outcomes for Virus-Driven ATLL Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 42(1):18,19,28, January 5, 2020. Favorites PDF Get Content & Permissions Free
Novel Targeted Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm Pemmaraju, Naveen Pemmaraju, Naveen Less Oncology Times. 42(1):1,11-12, January 5, 2020. Favorites PDF Get Content & Permissions Free
Midostaurin (Rydapt®) Lovell, Alexandra Lovell, Alexandra Less Oncology Times. 41(24):5, December 20, 2019. Favorites PDF Get Content & Permissions Free
Chemotherapy Can Set the Stage for Drug-Resistant Leukemia at Relapse Less Oncology Times. 41(24):1,8, December 20, 2019. Favorites PDF Get Content & Permissions Free
Debate: CML Patients With Molecular Response Should Stop Taking TKIs Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(23):1-3, December 5, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapeutic Approaches in Acute Leukemias Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(23):1,15-16, December 5, 2019. Favorites PDF Get Content & Permissions Free
Antibody Eradicates Leukemia Stem Cells Less Oncology Times. 41(22):1,6, November 20, 2019. Favorites PDF Get Content & Permissions Free
Exploring the CLL/Lymphoma Microenvironment to Improve Therapies Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 41(19):1,9-10, October 5, 2019. Favorites PDF Get Content & Permissions Free
Treatment of Patients With Advanced Chronic Myeloid Leukemia Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(19):1,5-6, October 5, 2019. Favorites PDF Get Content & Permissions Free
BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia Strati, Paolo; O'Brien, Susan M. Strati, Paolo; O'Brien, Susan M. Less Oncology Times. 41(17):1,6,7,8,29, September 5, 2019. Favorites PDF Get Content & Permissions Free
Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia Less Oncology Times. 41(16):1,7, August 20, 2019. Favorites PDF Get Content & Permissions Free
Childhood Leukemia Cannot Hide From Immune System Less Oncology Times. 41(14):7, July 20, 2019. Favorites PDF Get Content & Permissions Free
EHR Tool Finds Pediatric Leukemia Patients for Clinical Studies Less Oncology Times. 41(14):1,7, July 20, 2019. Favorites PDF Get Content & Permissions Free
SIRT1 Plays Key Role in Chronic Myeloid Leukemia Less Oncology Times. 41(13):1,8, July 5, 2019. Favorites PDF Get Content & Permissions Free
Enasidenib (Idhifa®) Lohr, Lisa Lohr, Lisa Less Oncology Times. 41(12):8, June 20, 2019. Favorites PDF Get Content & Permissions Free
Patterns of Chronic Lymphocytic Leukemia Growth Identified Less Oncology Times. 41(12):1,7, June 20, 2019. Favorites PDF Get Content & Permissions Free
Advice on Charting an Innovative Path Forward for Cell Therapies Eastman, Peggy Eastman, Peggy Less Oncology Times. 41(12):1,4,6, June 20, 2019. Favorites PDF Get Content & Permissions Free
Prolonged Survival Possible in FLT3 Acute Myeloid Leukemia Samson, Kurt Samson, Kurt Less Oncology Times. 41(10):28, May 20, 2019. Favorites PDF Get Content & Permissions Free
Genetic Alterations in Young Adults With Acute Lymphoblastic Leukemia Holt, Chuck Holt, Chuck Less Oncology Times. 41(10):1,8-9, May 20, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapies for Pediatric B-Cell Acute Lymphoblastic Leukemia Patients Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(9):15-18, May 5, 2019. Favorites PDF Get Content & Permissions Free
Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 41(9):1,7,9, May 5, 2019. Favorites PDF Get Content & Permissions Free
Glasdegib (Daurismo™) Lovell, Alex; Mann, Janelle E. Lovell, Alex; Mann, Janelle E. Less Oncology Times. 41(8):6, April 20, 2019. Favorites PDF Get Content & Permissions Free
New AML Treatment Achieves Positive Results Less Oncology Times. 41(8):19, April 20, 2019. Favorites PDF Get Content & Permissions Free
Genomic Analysis Guides Diagnosis & Treatment of High-Risk Leukemia Less Oncology Times. 41(8):1,16, April 20, 2019. Favorites PDF Get Content & Permissions Free
Genetically Encoded Sensor Isolates Hidden Leukemic Stem Cells Less Oncology Times. 41(7):1,31, April 5, 2019. Favorites PDF Get Content & Permissions Free
Characterizing the Mechanism of Action of CAR T Cells Less Oncology Times. 41(5):1,5, March 5, 2019. Favorites PDF Get Content & Permissions Free
Recommendations for New Plasma Cell Leukemia Diagnostic Criteria May, Brandon May, Brandon Less Oncology Times. 41(5):1-3, March 5, 2019. Favorites PDF Get Content & Permissions Free
Utilizing Computational Oncology to Better Understand AML & MDS Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 41(4):13, February 20, 2019. Favorites PDF Get Content & Permissions Free
FDA Approval: Ibrutinib Plus Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Less Oncology Times. 41(4):1,7, February 20, 2019. Favorites PDF Get Content & Permissions Free
Treatment of R/R Hairy Cell Leukemia With CD22-Targeting Immunotoxin Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(4):1-4, February 20, 2019. Favorites PDF Get Content & Permissions Free
More Accurate Leukemia Diagnosis Expected as Researchers Refine Classification Less Oncology Times. 41(3):1,8, February 5, 2019. Favorites PDF Get Content & Permissions Free
Leukemia Risks Associated With Childhood Exposure to Radiation Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(2):1,9,14, January 20, 2019. Favorites PDF Get Content & Permissions Free Take the CME Test
Molecularly Driven Screening Feasible for Previously Untreated AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(1):22, January 5, 2019. Favorites PDF Get Content & Permissions Free
Ibrutinib Plus Rituximab Improves Survival in Younger CLL Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(1):21, January 5, 2019. Favorites PDF Get Content & Permissions Free
Recurrent Mutation in BCL2 Protein Confers Resistance to Venetoclax Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(1):20, January 5, 2019. Favorites PDF Get Content & Permissions Free
Retinoid Shows Promising Responses in Non-APL Acute Myeloid Leukemia Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(1):19, January 5, 2019. Favorites PDF Get Content & Permissions Free
Tisagenlecleucel Demonstrates Sustained Remission in Pediatric ALL May, Brandon May, Brandon Less Oncology Times. 41(1):18, January 5, 2019. Favorites PDF Get Content & Permissions Free
Leukemia Hijacks the Microbiome to Glut Itself on Glucose Less Oncology Times. 40(21):1,4-5, November 5, 2018. Favorites PDF Get Content & Permissions Free
Trial Participation Influences Risk of Relapse in AYA Leukemia Less Oncology Times. 40(20):51, October 20, 2018. Favorites PDF Get Content & Permissions Free
Research Points to Potential Treatment Targets for Aggressive Leukemia Less Oncology Times. 40(19):61, October 5, 2018. Favorites PDF Get Content & Permissions Free
CLL Patient Treated at Penn Goes Into Remission Thanks to Single CAR T Cell Less Oncology Times. 40(19):40, October 5, 2018. Favorites PDF Get Content & Permissions Free
A First Look at a DNA Test to Predict Risk of Leukemia Relapse Less Oncology Times. 40(19):32, October 5, 2018. Favorites PDF Get Content & Permissions Free
New Combination Treatment Targets Pre-Leukemia Stem Cells Less Oncology Times. 40(19):9, October 5, 2018. Favorites PDF Get Content & Permissions Free
Solving a Central Mystery of a Baffling High-Risk Leukemia Less Oncology Times. 40(19):1,10, October 5, 2018. Favorites PDF Get Content & Permissions Free
Understanding Cancer Cell Mechanisms to Develop Novel Therapies for AML Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 40(17):26-27, September 5, 2018. Favorites PDF Get Content & Permissions Free
A Novel Biomarker Approach in MCL-1 Dependent Relapsed/Refractory AML Zeidner, Joshua Zeidner, Joshua Less Oncology Times. 40(17):1,9,35, September 5, 2018. Favorites PDF Get Content & Permissions Free
Applying Genomics to Leukemias & Lymphomas Parikh, Ankur R. Parikh, Ankur R. Less Oncology Times. 40(17):1,2,3,4,8, September 5, 2018. Favorites PDF Get Content & Permissions Free
Solving the Mystery of How ALL Enters the Central Nervous System Less Oncology Times. 40(16):32, August 20, 2018. Favorites PDF Get Content & Permissions Free
Examining the Genetic Makeup of Acute Myeloid Leukemia Less Oncology Times. 40(16):1,8, August 20, 2018. Favorites PDF Get Content & Permissions Free
Roots of Leukemia Reveal Possibility of Predicting People at Risk Less Oncology Times. 40(15):24, August 5, 2018. Favorites PDF Get Content & Permissions Free
New Drug May Be a Game Changer for Chronic Myeloid Leukemia Patients Marcucci, Guido Marcucci, Guido Less Oncology Times. 40(12):1,7, June 20, 2018. Favorites PDF Get Content & Permissions Free
New Drug May Be a Game Changer for Chronic Myeloid Leukemia Patients Marcucci, Guido Marcucci, Guido Less Oncology Times. 40(12):1,7, June 20, 2018. Favorites PDF Get Content & Permissions Free
Therapeutic Options for CML Patients Who Fail All TKIs Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(11):23, June 5, 2018. Favorites PDF Get Content & Permissions Free
CML & Pregnancy: Patient & Partner Considerations Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(11):22, June 5, 2018. Favorites PDF Get Content & Permissions Free
Novel Agents to Optimize CLL Therapy: In Combination or Sequentially? Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(11):21, June 5, 2018. Favorites PDF Get Content & Permissions Free
Tyrosine Kinase Inhibitor Therapy Can Be Stopped in Certain CML Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(11):20, June 5, 2018. Favorites PDF Get Content & Permissions Free
T-Cell Biomarker Predicts CLL Patients' Response to CAR T-Cell Therapy Less Oncology Times. 40(11):1,18, June 5, 2018. Favorites PDF Get Content & Permissions Free
Targeted Therapies for AML Ravandi, Farhad Ravandi, Farhad Less Oncology Times. 40(10):5-7, May 20, 2018. Favorites PDF Get Content & Permissions Free
Renegade Cells Foretell Relapse in Children With Leukemia Less Oncology Times. 40(8):1,15, April 20, 2018. Favorites PDF Get Content & Permissions Free
